insights_auto
Why is AGIO down ४.०३%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ २७.६०
arrow_downward
-४.०३%(-१.१६) 1D
US$ २७.६०
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २८.०१
High
US$ २९.१४
Low
US$ २७.४३
Mkt. cap
१.६५ अरब
Avg. vol.
११.२८ लाख
Volume
७.७६ लाख
52-wk high
US$ ४४.०७
52-wk low
US$ २३.०२
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Crypto Briefing
·
१ घण्टा पहिले
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
Yahoo Finance
·
१ घण्टा पहिले
The S&P 500 Just Whipsawed Near a Record High. Here’s Why I’m Lowering My Expectations, Not Selling.
24/7 Wall St.
·
७ मिनेट पहिले
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
TradingView
·
३ घण्टा पहिले
Yardeni Trims S&P 500 Year-End Forecast Again, Says Bear Market Is Unlikely
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc